Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neumentum

Neumentum?uq=2zON1W4M
2017 FOUNDED
PRIVATE STATUS
Series A1 LATEST DEAL TYPE
$5M LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a non-opioid analgesic and neurology specialty pharmaceutical company intended to provide the benefits of safe and effective pain management without the limitations and risks of abuse and misuse that come with opioids. The company's lead product is a novel, alcohol-free formulation of ketorolac in a pre-mixed bag for continuous IV infusion which has the potential to maintain pain relief at an opioid level, enabling physicians to reduce the use of opioids in clinical settings and transform the way pain is treated.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 252 Colorado Avenue
  • Palo Alto, CA 94301
  • United States

+1 (833) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Neumentum’s full profile, request a free trial.

Neumentum Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A1) 24-May-2018 $5M 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 25-Oct-2017 000 0000 0000 Completed Startup
1. Angel (individual) 28-Mar-2017 $5M $5M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Neumentum Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Neumentum Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Evolution Corporate Advisors Venture Capital Minority 000 0000 000000 0

Neumentum Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Shively Co-Founder, Chief Executive Officer & Board Member
Robert Raffa Ph.D Chief Scientific Officer
Taggart McGurrin Executive, Business Development and FP&A
Christine Mikail JD Chief Business Officer & Board Member
Ilona Steigerwald MD Chief Medical Officer

Neumentum Board Members (4)

Name Representing Role Since Contact
Info
Christine Mikail JD Neumentum Chief Business Officer & Board Member 000 0000
Joseph Pergolizzi MD Neumentum Board MemberCo-Founder & Executive Chairman of the Board 000 0000
Pedro Granadillo Self Board Member 000 0000
Richard Shively Neumentum Co-Founder, Chief Executive Officer & Board Member 000 0000